Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OCS compared with AGMB: revenue, margins and what each company keeps, and the suppliers and customers both name
OCS
Oculis Holding AG
Change
Mkt cap
Revenue
Revenue
AGMB
Agomab Therapeutics NV
Change
Mkt cap
Revenue
Revenue
vs
Compare
OCS
Oculis Holding AG
vs
AGMB
Agomab Therapeutics NV
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
No earnings history for OCS. No earnings history for AGMB.
OCS
Oculis Holding AG
Change
7.73
· pre 7.73
· delayed
Mkt cap
$463.3M
AGMB
Agomab Therapeutics NV
Change
6.68
· pre 6.68
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$255.9M
vs
Compare
Pre-market
Nov 2 '26
delayed
OCS
Oculis Holding AG
vs
AGMB
Agomab Therapeutics NV
7.73
pre 7.73
delayed
Price
6.68
pre 6.68
delayed
$463.3M
Mkt cap
$255.9M
Change
Change
OCS
7.73
vs
AGMB
6.68
Pre-market
Nov 2 '26
delayed